
ImmuONE is revolutionising how to assess the safety of inhaled chemicals and medicines by providing human-relevant alternatives to traditional animal testing. Addressing challenges with innovative lab-grown lung platforms designed to mimic human lung and immune system responses, these platforms provide a more accurate, predictive and ethical way to test the safety of chemicals, helping industries like pharmaceuticals and consumer products bring safer and more effective innovations to market.
- Investment status Current
- Invested 2023
- Category Health & Life Sciences